VRTX
Vertex Pharmaceuticals Inc
NASDAQ: VRTX · HEALTHCARE · BIOTECHNOLOGY
$427.38
+0.98% today
Updated 2026-04-30
Market cap
$108.71B
P/E ratio
27.93
P/S ratio
9.06x
EPS (TTM)
$15.30
Dividend yield
—
52W range
$363 – $508
Volume
1.3M
Vertex Pharmaceuticals Inc (VRTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-22.48M | $-252.48M | $-226.48M | $-427.59M | $-635.44M | $143.74M | $267.84M | $-51.57M | $-513.20M | $-365.43M | $236.10M | $844.94M | $1.27B | $1.57B | $3.25B | $2.64B | $4.13B | $3.54B | $-492.60M | $3.63B |
| Capital expenditures | $32.42M | $32.41M | $32.18M | $23.50M | $38.05M | $94.59M | $71.14M | $51.39M | $51.20M | $45.30M | $56.56M | $259.42M | $95.52M | $75.45M | $259.80M | $235.00M | $204.70M | $258.40M | $297.70M | $437.60M |
| Depreciation | $25.87M | $27.46M | $32.20M | $30.11M | $30.46M | $35.04M | $38.19M | $48.37M | $63.26M | $62.34M | $61.40M | $61.40M | $72.42M | $106.94M | $109.52M | $125.60M | $148.30M | $181.30M | $207.20M | $207.20M |
| Stock-based comp | $39.14M | $59.41M | $63.01M | $86.72M | $97.68M | $126.75M | $114.28M | $127.30M | $177.54M | $231.03M | $237.71M | $290.74M | $325.05M | $360.49M | $429.46M | $441.40M | $491.30M | $581.20M | $698.50M | $685.90M |
| Free cash flow | $-54.89M | $-284.89M | $-258.66M | $-451.08M | $-673.50M | $49.14M | $196.70M | $-102.96M | $-564.40M | $-410.73M | $179.54M | $585.52M | $1.17B | $1.49B | $2.99B | $2.41B | $3.93B | $3.28B | $-790.30M | $3.19B |
| Investing cash flow | $-208.47M | $405.17M | $-360.65M | $-508.73M | $7.30M | $212.41M | $-425.82M | $-54.13M | $73.96M | $268.86M | $104.47M | $-437.68M | $-202.16M | $-1.24B | $99.39M | $-340.90M | $-321.10M | $-3.14B | $-3.77B | $-945.40M |
| Financing cash flow | $365.87M | $-10.19M | $620.74M | $999.01M | $425.06M | $-124.24M | $172.20M | $180.88M | $497.38M | $188.92M | $133.27M | $68.40M | $-71.22M | $126.77M | $-505.28M | $-1.48B | $-67.70M | $-562.20M | $-1.49B | $-2.26B |
| Dividends paid | — | — | — | $290.56M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $20.84M | $10.05M | $264.95M | $102.00M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $-203.46M | $232.12M | $14.09M | $79.89M | $55.96M | $89.51M | $469.18M | $481.47M | $990.73M | $460.79M | $2.85B | $824.60M | $3.74B | — | — | — |